Prot#EIDOS AG10-201:A Phase 2, Randomized, Placebo-controlled, Dose-ranging Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AG10 in Patients with Symptomatic Transthyretin Amyloid Cardiomyopathy

Project: Research project

Project Details

StatusActive
Effective start/end date3/15/183/14/23

Funding

  • Eidos Therapeutics, Inc. (EIDOS AG10-201)